Skip to Main Content

Paper Details

The potential of PARP as a therapeutic target across pediatric solid malignancies.
BMC Cancer
2
2023
Ewing sarcoma, PARP, Pediatric cancer, TOP1, adult cancers, children, medulloblastoma, neuroblastoma, osteosarcoma, patients, pediatric, pediatric cancer, pediatric cancer cell lines, pediatric cancers, pediatric malignancies, pediatric solid malignancies, rhabdomyosarcoma, solid malignancies, solid pediatric malignancies, topoisomerase
Author NameAffiliation
Natalie J??gerHopp Children's Cancer Center (KiTZ)
Natalie J??gerGerman Cancer Research Center (DKFZ)
Natalie J??gerHopp Children's Cancer Center (KiTZ)
Natalie J??gerGerman Cancer Research Center (DKFZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolGerman Cancer Research Center (DKFZ)
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolPrincess Maxima Center for Pediatric Oncology
Marcel KoolHopp Children's Cancer Center (KiTZ)
Marcel KoolGerman Cancer Research Center (DKFZ)
Stefan M PfisterHopp Children's Cancer Center (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Stefan M PfisterHopp Children's Cancer Center (KiTZ)
Stefan M PfisterGerman Cancer Research Center (DKFZ)
Jan J MolenaarPrincess Maxima Center for Pediatric Oncology
Jan J MolenaarDepartment of Pharmaceutical Sciences, University Utrecht
Sander R van HooffPrincess Maxima Center for Pediatric Oncology
  • 1 - 17

Datasets

Dataset
Description
Source Link
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Genomics of Drug Sensitivity in CancerGenomics of Drug Sensitivity in Cancer: Sensitivity for anti-cancer drugs in various cell linesLink
Release 1.2